具有產(chǎn)生安莎類抗生素潛能的放線菌的分子篩選

1、具有產(chǎn)生安莎類抗生素潛能的放線菌的分子篩選                       作者：武臨專 張會圖 韓鋒 高群杰 孫桂芝 王以光 【摘要】  目的 建立一種高通量篩選具有產(chǎn)生安莎類抗生素潛能的放線菌的分子篩選方法。原理 3?舶被?5?摻腔?脖郊姿?(AHBA)是安莎類抗生素生物合成的前體。在通過氨基莽草酸途徑生物合成AHBA的過程中，AHBA合酶是

2、催化5?舶被?3?餐亞猹?5?餐蜒趺菟嶁緯?AHBA的一個特異性關(guān)鍵酶。AHBA合酶基因的存在可以作為放線菌菌株具有合成安莎類抗生素能力的一個必要而非充分的條件。AHBA合酶基因高度保守，通過PCR方法可以建立一種針對AHBA合酶基因存在與否的、具有安莎類抗生素產(chǎn)生潛能的放線菌菌株高通量篩選方法。論文論文參考網(wǎng)方法 根據(jù)已知AHBA合酶序列的相似性，設(shè)計了針對AHBA合酶基因中高度保守的一段755bp片段大小的PCR篩選寡核苷酸引物，用于從土壤中分離的未知放線菌高通量篩選。結(jié)論 從1900株土壤分離的未知放線菌中篩選獲得33株AHBA合酶基因陽性菌株，即具有安莎類抗生素產(chǎn)生潛能的放線菌菌株。

3、【關(guān)鍵詞】  安莎霉素類； AHBA合酶基因； 聚合酶鏈反應(yīng)； 分子篩選； 放線菌Ansamycins are characterized by a benzenic or naphthalenic quinoid based chromophore with an ansa?bridge linking one end of the chromophore with the other end by an amide linkage (Fig.1). The chromophore is generated from a mC7N unit derived from 3?amino

4、?5?hydroxybenzoic acid (AHBA) via aminoshikimate pathway; any remaining part of the chromophore, and the ansa? bridge are polyketide derived.Fig.1    All ansamycins use AHBA as the starter unit for their biosynthesis    Ansamycins showed a variety of biological activiti

5、es. Rifampicin, a semisynthetic derivative of rifamycin produced by Amycolatopsis mediterranei, is one of the most effective clinical treatments of mycobacterial infection. 17?allylamino?demethoxygeldanamycin (17?AAG), a semisynthetic derivative of geldanamycin produced by Strepromyces hygroscopicus

6、, is currently under clinical trials for tumor treatment1,2. Ansamycins are also potential anti?viral agents. For example, rifamycin could block the RNA?dependent DNA polymerases of retroviruses, geldanamycin could inhibit the replication of Herpes Simplex Virus type 1 (HSV?1) in vitro3.  

7、  Screening of novel ansamycins (and their producers) is of great importance in discovering promising drug?candidates or lead compounds with clinical potentials. During the past ten years, several ansamycins produced by streptomyces strains were discovered such as thiazinotrienomycins and cytot

8、rienin A, both of them showed antitumor activities47. Some novel ansamycins were also obtained successfully by means of chemical and/or biological modifications of known ansamycins8.    Up to now, most natural ansamycins are discovered by activity?based screening of microbial (especia

9、lly, actinomycetes) fermentation and extraction of products. That is, a screening model was established first, based on detecting (assaying) a certain kind of biological activity, then the compound with such an activity was isolated and purified for further structural elucidation. In spite of the su

10、ccess of activity?based screening for ansamycins, their obvious disadvantages include: the limitations of the fermentation condition and the minimal bioactivity detection lead to missing the potential ansamycin in the initial screening; the structure determination complexity of numerous related chem

11、istry resulted in blindfold laborious efforts for aimed screening of ansamycin; the difficulties in setting?up the high?throughput screening program.    We are interested in establishing a screening model that is ansamycin?targeted. From the biosynthetic viewpoint, AHBA, synthesized b

12、y so called aminoshikimate pathway, is the starter unit for all ansamycins. The aminoshikimate pathway, clarified by Floss HG et al9,10, involved a sequential biochemical reactions parallel (but different) in partial to the well?known shikimate pathway for aromatic amino acid biosynthesis. Compariso

13、n of the aminoshikimate pathway and the shikimate pathway revealed a terminal aromatization reaction unique to the aminoshikimate pathway that convert the 5?amino?3?dehydro?5?deoxyshikimate into AHBA, catalyzed by the AHBA synthase. Using AHBA synthase gene as a probe, the biosynthetic gene clusters

14、 of many AHBA?derived natural compounds have been identified1113. With the accumulation of more and more sequence data of AHBA synthases, it is safe to conclude that all AHBA synthases are highly similar each other. We believe that the existence of AHBA within actinomycetes strain could be used as a

15、n indicator for ansamycin biosynthesis. As AHBA is a small aromatic molecule and an intermediate specifically involved in secondary metabolism, its simple and easy detection remains an unsolved problem. As an alternative, the highly conserved AHBA synthase gene could be easily detected by, e.g., PCR

16、, and it could be used as a gene?marker of the biosynthetic potential of AHBA. So the AHBA synthase gene could be used in place of AHBA for the preliminary screening of potential ansamycin producers.    In this paper, an ansamycin?targeted molecular screening model was successfully de

17、veloped, which can be used for screening systemically of actimomycetes strains with ansamycin production potentials by PCR in a high?throughput manner. Positive actimomycetes strains from this screening model could be used for further exploring the real ansamycin producers.    1 

18、 Materials and methods    1.1  Strains    Seven strains producing antibiotics other than ansamycins, Streptomyces griseolus CPHCC200279 for anisomycin, Actinoplanes luojiashanensis CPHCC200063 for dihydroxy anthraquinone, Streptomyces violaceus CPHCC200533 for viol

19、arine, Streptomyces viridochromogenes CPHCC200311 for xanthomycin, Streptomyces sp. CPHCC200014 for pluramycinA, Streptomyces spiramyceticus 200108 for spiramycin, and Saccharopolyspora erythraea CPHCC200101 for erythromycin. Four ansamycin?producing strains, Amycolatopsis mediterranei var. kanglens

20、is CPHCC200092 for kanglemycin A14, Amycolatopsis mediterranei CPHCC200067 for rifamycin, Nocardia sp. CPHCC200096 for macbecin15, Streptomyces hygroscopicus CPHCC200178 for geldanamycin11. 1900 random?selected, unspecified actinomycetes strains from soil isolates, each as liquid fermentation cultur

21、e. All the strains were provided kindly by Center for Culture and Collection of Pharmaceutical Microorganisms (CPHCC, China).    1.2  Reagents    TaKaRa LA TaqTM with GC Buffer kit (for all PCR amplifications), agarose gel DNA fragment recovery kit ver. 2.0, restri

22、ction enzymes, and pMD19?T vector were all purchased from TaKaRa Biotechnology (Dalian) Co., Ltd. Polyvinylpyrrolidone?4000 (PVP?4000), a product of Amresco purchased from Shanghai Sangon Biological Engineering Technology and Service Co., Ltd. DNA molecular weight marker III (200bp, 500bp,800bp,1200

23、bp, 2000bp,3000bp, and 4000bp) was purchased from Beijing Dingguo Biotechnology Co. Ltd.    1.3  Extraction of genomic DNA from actinomycetes strains    A modified procedure for genomic DNA extraction from liquid culture of actinomycetes strains in eppendorf tubes

24、was developed from reference16. Briefly, for each actinomycetes strain, 70l of liquid culture was drawn into an 1.5ml eppendorf tube, centrifuged at 10,000r/min for 1min, the supernant was discarded. Then 1ml Washing Solution (Tris?HCl 50mmol/L, EDTA 25mmol/L, PVP?4000 0.1%, pH7.7) was added into th

25、e tube, vortexed for 5s, centrifuged at 10,000r/min for 2min, discarded the supernant. 150l Lysis Buffer (Tris?HCl 50mmol/L, EDTA 25mmol/L, SDS 3%, PVP?4000 1.2%, pH8.0) was added into the pellet and mixed well by vortexing for 5s. It was then put into a microwave oven and heated to just nearly boil

26、ing. 450l Extraction Buffer (Tris?HCl 10mmol/L, EDTA 1mmol/L, NaAc 0.3mol/L, PVP?4,000 1.2%, pH8.0) was added and mixed up and down by pipeting for a few times, then an equal volume of phenolchloroformisoamyl alcohol (25241) was added and mixed up and down for 35min. After centrifuging at 10,000r/mi

27、n for 2min, the supernant was pipeted into a new 1.5ml eppendorf tube and precipitated with an equal volume of isopropyl alcohol. The pellet was washed with 70% alcohol, dried, and dissolved in 20l TE buffer with RNaseA (40g/ml), then it can be used as template for PCR. For pooled genomic DNA extrac

28、tion of 10 actinomycetes strains, 40l of the liquid culture of each strain were mixed in an eppendorf tube, then following the extraction procedure above.    1.4  PCR amplification of AHBA synthase genes    Two pairs of degenerative oligonucleotides, 755a (5?agagga

29、tccTTCGAGCRSGAGTTCGC?3, small letters are those added for easy cloning, same below) and 755b (gcaggatccGGAMCATSGCCATGTAG?3), 235a (5?GAGGTSATCGTSCCSGCSTTC?3) and 235b (5?TGSGCGTGSGCSGCGTCCTG?3) were designed to amplifiy, respectively, a 755bp portion and a 235bp portion of the highly conserved AHBA

30、synthase genes. For each PCR amplification reaction, the following procedure was followed. In an 15l PCR system, adding: Taq LA 2×GC Buffer I 7.5l; ddH2O 5l; dNTP (2.5mmol/L) 0.5l; primers (755a/755b; or 235a/235b), each 0.5l (to a final concentration of 20mol/L); genomic DNA 1l; Taq LA (TaKaRa

31、) 0.5U. The PCR parameters were denaturing at 96 for 25s, annealing at 58 for 25s, extension at 72 for 1min, 30 cycles. 45l of PCR amplification product was used for agarose gel (1%) electrophoresis analysis.論文參考網(wǎng)    1.5  Screening of actinomycetes strains with AHBA synthase gene

32、 by PCR    Pooled genomic DNAs of 10 different actinomycetes strains were used as template for PCR amplification/detection of the 755bp portion of AHBA synthase gene. The overall strategy for high?throughput screening of actinomycetes strains with AHBA synthase gene is illustrated in

33、Fig.2.    1.6  Sequencing and blast analysis of PCR product    DNA amplification products of 755bp were recovered and purified from agarose gel. Most DNA recovery samples could be sent for direct sequencing, but some samples needed to be cloned into vectors (e.g.,

34、pMD19?T) before sequencing. DNA sequencing services were accomplished by TaKaRa Biotechnology (Dalian) Co.,    Fig.2    Schematic diagram of the PCR screening procedure for AHBA synthase gene    positive strains. Each number of 110 and each letter of A?J

35、represented a    pool of 10 strains genomic DNA. The cross of two positive pools, like 5E,    was chosen for subsequent single strain PCR screeningLtd. The DNA sequencing data were then blast?analyzed on NCBIs nucleotide data bank (/BLAST) to o

36、btain similarity parameters with published AHBA synthase genes.    1.7  Nucleotide sequence accession numbers    Sequence data have been deposited with GenBank and assigned the accession number from EU178762 to EU178794, which can be retrieved by Entrez PopSet as a

37、 group.    2  Results    2.1  Oligonucleotides 755a/755b are suitable for targeted screening of potential ansamycin producers    Five known AHBA synthases for ansamitocin (AAC13997), mitomycin C (AAD32723), ansatrienin (AAD31835), rifamycin (AAC

38、01720), and naphthomycin (AAD31828) from NCBI were chosen for multiple alignment (http:/bioinfo.genopole?toulouse.prd.fr/multalin/multalin.html). Two pairs of oligonucleotides (see 1.4) were designed and synthesized, then tested for their specificity and effectiveness for PCR amplification of AHBA s

39、ynthase genes using four strains (see 1.1) as positive controls for ansamycin producers, and seven carefully chosen strains (which can be divided into two groups, one group of first five strains producing antibiotics with aromatic moiety ring, the other group of last two strains producing macrolide

40、antibiotics. See 1.1) as negative controls for non?ansamycin producers. Both pair of oligonucleotides produced expected DNA amplification fragments from the four positive controls, and both pairs of oligonucleotides failed to generate expected DNA amplification fragments from the seven negative cont

41、rols. These results suggested that PCR screening for potential ansamycin producers was practicable. The oligonucleotides, 755a/755b showed a better specificity for PCR amplification of AHBA synthase gene in the positive controls. Sequencing and blast analysis of the four 755bp DNA fragments amplifie

42、d by the pair of oligonucleotides 755a/755b, suggested that they all belonged to AHBA synthase genes. Therefore, the pair of oligonucleotides, 755a/755b, was chosen for large?scale PCR screening of actinomycetes strains with ansamycin producing potentials.    2.2  A total of 33 p

43、otential ansamycin?producing actinomycetes strains obtained    To facilitate the screening process, a high?throughput screening strategy (see Fig.2) was developed by pooled?amplification of a mixture of genomic DNAs of 10 actinomycetes strains, which saved both labor and time, and the

44、refore made screening more convenient and cost?effective.    Each 755bp DNA fragment amplified by PCR were sequenced and blast?analyzed with NCBI GenBank (Blastn and Blastp). It was very easy to identify each of the 755bp DNA sequence as being the AHBA synthase gene or not, because al

45、l AHBA synthases shared very high similarity/identity percentages. Amino acid sequences of each 755bp DNA fragment was then multi?aligned with known AHBA synthases to check if it fit well with the 67 nearly?unvariable sequence blocks. A total of 33 AHBA synthase genes were obtained.   

46、; 3  Discussions    The AHBA synthase gene had been used as a probe, to clone successfully the biosynthetic gene clusters of several ansamycins such as rifamycin, geldanamycin, etc. It is based on these successes that a high?throughput screening method, which detects the existenc

47、e of AHBA synthase gene, for potential ansamycins producers was developed in this paper.    Because of the varieties of biological activities ansamycins displayed, it is nearly impossible to establish an activity?based assaying screening model suitable for screening all ansamycins. Th

48、ere were some novel ansamycins disclosed during the past ten years, but they were all discovered by certain kinds of activity?based screening models47.    There are several reports about PCR screening of actinomycetes strains with potentials to biosynthesize, for examples, aromatic ma

49、crolides and macrolactone macrolides17,18. All these PCR screening methods are based on the amplification of a specific fragment/portion of a highly conserved gene that is indispensable for the biosynthesis of antibiotics with certain structures. As an extension of the PCR screening strategy, Zazopo

50、ulos et al.19 established a genomics?guided approach to search for actinomycetes strains with the potential to biosynthesize antibiotics with enediyne structure, which probed the existence of a cassette of 5 conserved genes that encoded the 5 essential enzymes for enediynes biosynthesis.  

51、  Of the 1900 actinomycetes strains screened in this study, 1.74% were AHBA synthase gene positive. If this is a typical case of all the actinomycetes strains in nature, then ansamycins may not be a class of scarce secondary metabolites of actinomycetes.    AHBA, the starter unit

52、 for all kinds of ansamycins, may also be employed for the biosynthesis of other secondary metablites of microorganisms, although this is a vary rare case. As an example, Toshikazu Komoda reported recently the biosynthesis of tetrapetalones, which utilized AHBA as one of its building units (possible

53、, the starting unit) of biosynthsis20. We believe that most of the 33 AHBA synthase gene positive strains obtained in this study are potential ansamycins producing strains, but one or a few of them may be potential other than ansamycins producing strains that utilize AHBA as their biosynthetic build

54、ing blocks.    Although the oligonucleotides 755a/755b were designed for amplification of AHBA synthase genes, their specificity was not absolute. Bioinformatic analysis of the 755bp DNA were necessary. One 755bp DNA fragment (No.22157) was eliminated after sequencing and blast analys

55、is (part of this 755bp DNA showed high similarities to genes encoding the nitrile hydratase activator or cobalamin synthesis protein from some microorganisms).    This paper provided a simple and easy way for discovering, systemically, potential ansamycins producing strains. For the d

56、iscoveries of novel ansamycins from the fermentation cultures of these AHBA synthase gene positive strains, chemical data such as TLC and MS?MS, with known ansamycins (many commerially available) as references for comparison, are needed to eliminate first those which belong to known ansamycins. Sequ

57、ence comparison/alignment of AHBA synthase genes could not provide convincible evidences for novel ansamycins production, as all the AHBA synthase genes are highly conserved.    According to our incomplete collection and analysis of published articles, about 4050 different kinds of na

58、tural ansamycins have been discovered, with the majorities of them being produced by actinomycetes. It is believed there are still a lot of novel ansamycins to be discovered, because the combinations of the ansa?bridge variations in length and reduction level, the different substituting groups on th

59、e ansa? bridge and the chromophore, and the two kinds of chromophores (the benzenic and the naphthalenic based aromatic rings) should result in far more than 50 different kinds of structures of ansamycins. At present, the AHBA synthase gene positive strains obtained in this study are under intensive

60、 investigation of their ansamycin producting abilities.    It is worthy to note that the screening strategy employed in this paper should aslo be applicable to the systemic screening of potential producing strains of aminoglycosides, anthracyclines, ?lactams, macrolides, non?ribosomal

61、 peptides, etc, if some essential biosynthetic gene(s) is/are selected and then targeted?screened by PCR.【參考文獻】  1 Weigel B J, Blaney S M, Reid J M, et al. A phase I study of 17?allylaminogeldanamycin in relapsed/refractory pediatric patients with solid tumors: a Childrens Oncology Group study J. Clin Cancer Res,2007,13(6):17891793.2 Solit D B, Ivy S P, Kopil C, et al. Phase I trial of 17?allylami